ส่วนผสมทางเภสัชกรรม

Sheffied Tabletting System Disintequik MCC 25 is a co-processed excipient consisting of 75% Alpha monohydrate lactose and 25% Microcrystalline Cellulose (MCC). The processing results in a co-agglomeration compound of the two ingredients, spray dried lactose and MCC, preserving the identity of each component. Prior to processing, both ingredients meet all of the requirements as outlined in the current monographs of the EU, JP and NF. Disintequick MCC 25 reduces raw materials QC Testing, Manufacturing Steps and process validation. A Drug Master File is available. Added benefits include: reduction of blending issues, low dust generation, the avoidance of costly wet granulation processes, improved flowability and content uniformity during compression.

The proprietary process used to manufacture Mannogem EZ Spray Dried - Mannitol yields a porous material with lower disintegration times, a narrow particle size distribution, enhanced flow, and compression properties. It is due to these properties that Mannogem EZ is excellent in ODT formulations. It produces tablets with higher hardness than other excipients at comparable compression forces, and its higher surface area allows Mannogem EZ to work well as a base for ordered mixing with micronized APIs and low dose formulations. Mannogem® Mannitol products are manufactured from sugar cane or from corn starch/syrup.

BICAR®PHARMA API is suitable to be used as active pharmaceutical ingredient (API) in Antacid formulations like tablets, Capsules and Liquid oral formulation. It is also used as a Buffering agent and in effervescent formulations. Also used in effervescent tablets of lipid lowering agent.

Pharmaburst ® C1 a mixture of a disintegrant, a flow agent and particles having a non-filamentous microstructure of at least two sugar alcohols, a supplemental sugar alcohol, a supplemental flow agent, and a supplemental disintegrant.